Table 2.
CD57 and perforin expression in CD3+CD8+ T cells before and after acute exercise.
| Base | 0 h | 2 h | 24 h | ||
|---|---|---|---|---|---|
| CD8+CD57+ (×103 cells/µl) | Total | 105 ± 23 | 184 ± 24** | 83 ± 24 | 111 ± 23 |
| ADT | 92 ± 36 | 204 ± 43 | 90 ± 41 | 56 ± 38 | |
| PCa | 110 ± 38 | 150 ± 38 | 68 ± 38 | 111 ± 38 | |
| CON | 113 ± 46 | 199 ± 46 | 93 ± 46 | 166 ± 46 | |
| CD8+CD57+ (%) | Total | 42.2 ± 3.2 | 35.6 ± 3.4 | 46.3 ± 3.1 | 42.0 ± 3.3 |
| ADT | 34.3 ± 5.1#,† | 26.6 ± 6.3#,† | 33.8 ± 5.3 #,† | 27.0 ± 5.1 #,† | |
| PCa | 47.6 ± 5.3 | 44.1 ± 5.1 | 42.4 ± 5.1 | 48.2 ± 5.1 | |
| CON | 44.7 ± 6.3 | 36.1 ± 6.3 | 62.8 ± 5.9 | 50.7 ± 6.9 | |
| CD8+Perf+ (×103 cells/µl) | Total | 105 ± 23 | 184 ± 24** | 83 ± 24* | 111 ± 23 |
| ADT | 92 ± 36 | 204 ± 43 | 90 ± 41 | 56 ± 38 | |
| PCa | 110 ± 38 | 150 ± 38 | 68 ± 38 | 111 ± 38 | |
| CON | 113 ± 46 | 199 ± 46 | 93 ± 46 | 166 ± 46 | |
| CD8+Perf+ (%) | Total | 71.2 ± 4.0 | 56.7 ± 4.3 | 58.7 ± 3.9 | 52.9 ± 3.9 |
| ADT | 62.5 ± 6.3 | 61.6 ± 7.9 | 39.0 ± 6.1* | 49.4 ± 6.1 | |
| PCa | 76.3 ± 6.3 | 60.1 ± 6.3 | 59.5 ± 6.1 | 60.6 ± 6.1 | |
| CON | 74.7 ± 7.9 | 48.4 ± 7.9* | 77.7 ± 7.4 | 48.8 ± 7.7* | |
| CD8+Perf+ (GMFI) | Total | 2,398 ± 439 | 3,167 ± 464 | 3,259 ± 433 | 3,094 ± 433 |
| ADT | 3,918 ± 688 #,† | 4,868 ± 848 #,† | 3,735 ± 688 #,† | 5,633 ± 688 #,† | |
| PCa | 1,871 ± 718 | 2,348 ± 688 | 3,955 ± 688 | 2,578 ± 688 | |
| CON | 1,404 ± 862 | 2,286 ± 862 | 2,086 ± 862 | 1,073 ± 862 |
Mean ± SE from the estimated marginal mean. When statistical significance is indicated on the Total, this represents a main effect. GMFI, geometric mean fluorescent intensity.
P < 0.05
P < 0.01 vs. baseline.
P < 0.05 vs. CON.
P < 0.05 vs. PCa.